Outcomes of endoscopic gasless subcutaneous mastectomy and conventional open surgery for gynaecomastia: a prospective study
摘要
The prevalence of gynaecomastia, a benign condition in males, is significantly impacting young, productive individuals’ physical, social, and emotional well-being. The standard surgical management, known as traditional open subcutaneous mastectomy, negatively affects self-confidence and body image as it often leaves disfiguring periareolar scars.
This study aims to assess the short-term outcomes of gasless endoscopic surgery, with emphasis on operating time, hematoma/seroma requiring intervention, and pain. Patient satisfaction is also compared against cosmetic outcomes.
MethodsA total of 38 patients with Simon grade 2 and 3 gynaecomastia were recruited for this prospective study and divided into two groups: Group A (n = 15) underwent conventional subcutaneous mastectomy, while Group B (n = 23) underwent endoscopic gasless subcutaneous mastectomy. Operative findings, complications, and patient satisfaction were recorded and assessed at 1 week, 1 month, and 3 months post-op.
ResultsExcluding two patients in Group A with unilateral gynaecomastia, nearly all the participants exhibited bilateral gynaecomastia. Group A demonstrated a higher mean total breast weight compared with Group B (439.27 ± 268.91 g vs. 413.61 ± 256.33 g, p = 0.111). The mean operative duration was comparable between groups (129.33 ± 59.10 min vs. 122.61 ± 30.84 min, p = 0.297). Minimal intraoperative blood loss was observed in both groups, with similar rates of postoperative hematoma requiring intervention (13.3% vs. 13.0%, p = 0.979). Group A demonstrated a significantly higher rate of 1-month postoperative complications compared with Group B (66.6% vs. 21.7%, p = 0.049). Although no statistically significant differences were identified in BREAST-Q domain scores, patients in the endoscopic group demonstrated numerically higher psychosocial and physical well-being scores.
ConclusionsGasless endoscopic subcutaneous mastectomy appears to be a feasible and safe minimally invasive alternative to conventional open surgery for selected patients with gynecomastia. While perioperative outcomes were generally comparable between groups, the endoscopic approach demonstrated favourable trends in patient-reported outcomes and cosmetic satisfaction. Larger studies with longer follow-up are required to validate these findings. Level of Evidence: Level III, therapeutic study.